about
Genomic amplification of orthodenticle homologue 2 in medulloblastomasMolecular subgroups of medulloblastoma: the current consensusGene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypesExpression of stabilized beta-catenin in differentiated neurons of transgenic mice does not result in tumor formation.Identification of astrocytoma associated genes including cell surface markersIncreased p53 immunopositivity in anaplastic medulloblastoma and supratentorial PNET is not caused by JC virusNotch signaling in prostate cancer: a moving targetPathological and molecular advances in pediatric low-grade astrocytomaCyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastomaMultiple recurrent genetic events converge on control of histone lysine methylation in medulloblastomaSubgroup-specific alternative splicing in medulloblastomaSubgroup-specific structural variation across 1,000 medulloblastoma genomesDiagnosis of intravascular lymphoma by a novel biopsy siteIntegrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomeHighly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the BrainModerate reduction of gamma-secretase attenuates amyloid burden and limits mechanism-based liabilitiesScleral penetration of an unusually aggressive case of a retinal hemangioblastoma.Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma.A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue.NRF2 plays a protective role in diabetic retinopathy in miceThree-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.Ectopic recurrence of craniopharyngioma after an interhemispheric transcallosal approach: case report.Management of pediatric and adult patients with medulloblastoma.DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues.Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cellsEpilepsy and temporal lobe injury after skull base proton beam therapy.RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio- and chemotherapy in childhood medulloblastoma cells.Unfolded protein response in fuchs endothelial corneal dystrophy: a unifying pathogenic pathway?Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model.Regulation of sonic hedgehog-GLI1 downstream target genes PTCH1, Cyclin D2, Plakoglobin, PAX6 and NKX2.2 and their epigenetic status in medulloblastoma and astrocytoma.HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells.c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients.BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenograftsLong-term, stable differentiation of human embryonic stem cell-derived neural precursors grafted into the adult mammalian neostriatumSequence survey of receptor tyrosine kinases reveals mutations in glioblastomasHypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheresDNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation.NKX3.1 as a marker of prostatic origin in metastatic tumors.
P50
Q24294737-2E2F468D-47D4-4A8B-9B96-3622F3F95543Q24615271-701433B0-F906-4C29-B467-7074298DFC1EQ24647891-FD233A64-5C1C-4F3A-8BA3-EECD71280FEAQ24794618-E0F44508-C54E-4EEA-94BC-84496A5AC7DBQ24795833-F5AF8724-528F-4F9B-BA70-EE8349EB01AFQ24801678-D2624996-5DD7-420D-8B60-5B2A513E1937Q27001047-ED24E6AB-A197-45D6-98DA-DB95C27FC2CDQ27026123-832F03EE-435A-43FB-BDF8-C79A5FED9FBBQ28236409-5B970DF3-9014-462B-90BB-92D124032E84Q28237604-11ED4FD5-ED88-44B8-A258-157CECBF0ABDQ28260516-029FA78D-27CC-4AB5-B502-416731C873B6Q28271811-D5166175-7E4D-43EB-9633-6CF71A995C8FQ28297197-8E65A889-DDC6-47E4-AB3C-376B4459E49FQ28298987-197508A6-776B-476A-AF4B-9BEAE23ED0B3Q28394137-73DDC88D-8F21-4DEB-9404-88D42F482C9EQ28588005-A55E3365-E130-4416-A16F-F697D86E2B91Q30439369-CACF278E-E594-442B-9A83-0A48D48868A5Q30445148-2CCA6B68-044E-4152-BA08-D5FF7DDC6666Q30541682-3886CB4C-FDC1-44A0-8628-8F74E64980F6Q30579323-C22A3C8D-7901-45A9-A424-16109534EF24Q30594301-296D3866-B3EA-4E6B-B292-03F9B2BD693BQ30673273-58399FB3-93E1-4534-8F75-4675BAE1AC71Q30847947-D0812B6C-5B44-4BC9-AD95-A73BEF9DC36CQ31068101-ADE065E5-FB82-41A6-907E-8FED7891795FQ33252671-907E6E28-303A-4419-91AA-07375344AD00Q33270402-29E47DA1-EAD4-4F9C-851A-8A6F9948BE06Q33273447-5DDD8A61-BD73-4593-98B1-75F651B52CFBQ33398834-4ED06FB5-9CA2-45A0-86C4-A749AAB3AE19Q33617806-51A324F8-F58C-4E6D-A9EB-2DA6B4FE391CQ33642356-1325924A-1F2A-4162-93CA-A40A4749D0ECQ33741183-A9A82791-294B-443B-BDC4-DEB6D75C1427Q33760690-5CD14FCC-BD68-4EF1-8058-79557F769F0DQ33821504-181BA979-EDB4-475D-8845-192AF4C4036DQ33862879-45486030-CB8A-43A5-9C88-8AE0B7A6BF3EQ33883897-BF54129D-9560-4A90-AE3D-AA808CD61E0DQ34003304-24F8D299-C0C0-4F15-8C9D-8889059D647FQ34063705-F3651FED-BD01-42C7-81E4-9947340DCE00Q34087018-C3D39E27-CDD0-4E6B-8540-E06C3D286EDBQ34111103-BF53E232-E85B-403E-8C50-6E7E467BDD2BQ34123290-C725465A-53F8-474A-98C2-51960A485709
P50
name
Charles G Eberhart
@en
type
label
Charles G Eberhart
@en
prefLabel
Charles G Eberhart
@en